These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 845024)

  • 1. Variation of plasma free tryptophan and CSF 5-HIAA during migraine.
    Hyypp MT; Kangasniemi P
    Headache; 1977 Mar; 17(1):25-7. PubMed ID: 845024
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervals.
    Kangasniemi P; Sonninen V; Rinne UK
    Headache; 1972 Jul; 12(2):62-5. PubMed ID: 5056180
    [No Abstract]   [Full Text] [Related]  

  • 3. [CSF levels of 5-HIAA in migraine during tryptophan therapy (author's transl)].
    Poloni M; Nappi G; Kauchtschischvili G; Savoldi F
    Riv Patol Nerv Ment; 1974 Oct; 95(5):620-3. PubMed ID: 4470262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in patients with migraine before and after treatment with L-tryptophan].
    Nappi G; Poloni M; Bono G; Savoldi F
    Boll Soc Ital Biol Sper; 1974 Jul; 50(14):1037-42. PubMed ID: 4463996
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in serotonin metabolism during migraine attacks.
    Kangasniemi PJ
    Monogr Neural Sci; 1976; 3():60-6. PubMed ID: 979998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid 5-hydroxyindoleacetic acid level in migrainous patients during spontaneous attacks, during headache-free periods and following treatment with L-tryptophan.
    Poloni M; Nappi G; Arrigo A; Savoldi F
    Experientia; 1974 Jun; 30(6):640-1. PubMed ID: 4837086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in patients with migraine during attacks and in the intercritical period].
    Poloni M; Nappi G; Tartara A; Arrigo A; Bono G
    Boll Soc Ital Biol Sper; 1974 Jul; 50(14):1031-6. PubMed ID: 4463995
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.
    Williams WA; Shoaf SE; Hommer D; Rawlings R; Linnoila M
    J Neurochem; 1999 Apr; 72(4):1641-7. PubMed ID: 10098872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females.
    Kirwin PD; Anderson GM; Chappell PB; Saberski L; Leckman JF; Geracioti TD; Heninger GR; Price LH; McDougle CJ
    Life Sci; 1997; 60(12):899-907. PubMed ID: 9061047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin metabolism in migraine.
    Ferrari MD; Odink J; Tapparelli C; Van Kempen GM; Pennings EJ; Bruyn GW
    Neurology; 1989 Sep; 39(9):1239-42. PubMed ID: 2475821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular size and CSF transmitter metabolite concentrations in severe endogenous depression.
    Standish-Barry HM; Bouras N; Hale AS; Bridges PK; Bartlett JR
    Br J Psychiatry; 1986 Apr; 148():386-92. PubMed ID: 2425882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid (CSF) investigations in migraine.
    Kovács K; Bors L; Tóthfalusi L; Jelencsik I; Bozsik G; Kerényi L; Komoly S
    Cephalalgia; 1989 Mar; 9(1):53-7. PubMed ID: 2468418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
    Sourkes TL; Young SN; Garelis E; Lal S
    Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 5-hydroxytryptamine (5-HT) in migraine during an attack-free period.
    Nagata E; Shibata M; Hamada J; Shimizu T; Katoh Y; Gotoh K; Suzuki N
    Headache; 2006 Apr; 46(4):592-6. PubMed ID: 16643553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease.
    Sullivan PA; Murnaghan D; Callaghan N; Kantamaneni BD; Curzon G
    J Neurol Neurosurg Psychiatry; 1980 Aug; 43(8):739-43. PubMed ID: 6159456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan in hepatic coma.
    Sourkes TL
    J Neural Transm Suppl; 1978; (14):79-86. PubMed ID: 290743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC assays of 5-HIAA and tryptophan in cerebrospinal fluid and 5-HT and tryptophan in blood: a methodological study with clinical applications.
    Larsson M; Forsman A; Hallgren J
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):453-60. PubMed ID: 2458513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma tryptophan in migraine.
    Salmon S; Fanciullacci M; Bonciani M; Sicuteri F
    Headache; 1978 Jan; 17(6):238-41. PubMed ID: 621142
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid analyses in migraine patients and controls.
    Rothrock JF; Mar KR; Yaksh TL; Golbeck A; Moore AC
    Cephalalgia; 1995 Dec; 15(6):489-93. PubMed ID: 8706112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.